Effective in closing transactions
Our long-standing experience and a global network of offices allow us to ensure for our clients the best terms in transactions.
See below selected transactions from recent years.
Touch to read more.
Sell-side Advice
Sale of 100% shares
Investor
2023 - Poland
Holon-Translink advises Spedimex on sale of 100% shares of the company to ID Logistics
MoreSell-side Advice
Majority stake sale
Investor
2022 - Polska
Holon introduces strategic investor to Fox Recykling
MoreSell-side Advice
Sale of the majority of the shares
Investor
2022 - Poland
Transaction advisory to the owners of Elektrotermex (ETX) on gaining Viessmann strategic investor
MoreBuy-side Advice
Acquisition of 100% shares
Target company
2022 - Poland
M&A advisory to owners of Klinika Bocian – the leading centers providing infertility treatment, gynecology and obstetrics services in Poland – in the process of purchase of...
MoreSell-side Advice
Sale of 100 % shares
Investor
2022 - Poland
Transaction advisory to JCommerce's owners on sale of 100% shares of the company to Inetum Group
MoreBuy-side Advice
Acquisition of 100% shares
Target company
2022 - France
Capital advisory to Barentz, the global life science ingredients distributor, in the process of acquisition of Unipex Group
MoreSell-side Advice
Majority stake sale
Investor
2022 - Finland
Transaction advisory to the owners of Studeo on gaining Klett Group strategic investor
MoreSell-side Advice
Sale of 100% shares
Investor
2022 - United Kingdom
Translink advised Peak Proteins of the 100% sale to Sygnature Discovery
MoreSell-side Advice
Sale of subsidiaries
Investor
2022 - Spain
Capital advisory to Grupo MFI on the sale of its operating subsidiaries Ibervisión, Medop and Elaboria to Fielmann AG
MoreSell-side Advice
Sale of 100% shares
Investor
2022 - France
Capital advisory on the sale of a company to Sylvatek - a manufacturer of large format wood packaging specialized for the food, construction and industrial markets.
MoreSell-side Advice
Sale of 100% shares
Investor
2022 - Germany
Capital advisory on the sale of a company to the owners of Pharma Insight - offering comprehensive market research for the pharmaceutical and healthcare markets.
MoreSell-side Advice
Sale of 100% shares
Investor
2022 - Italy